Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in ...

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

A deficiency of dopamine: how does Parkinson’s disease affect the body? Unlike levodopa, which, when it reaches the brain gets converted to dopamine, the drug in question, tavapadon, activates ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

What if the key to a greener future wasn’t in high-tech gadgets or sweeping legislation, but in mushrooms, plant cells, and even food waste? As the world scrambles to combat climate change and reduce ...

The advent of CRISPR gene editing has enabled the creation of gene drives, a technology that can increase the odds of a certain gene being inherited. While the technology could help us tackle malaria ...

An unsustainable demand for meat has led to companies looking for alternative solutions to conventional farming methods in order to change the way we eat and think about meat. For biotech companies in ...